Pluslife is currently unveiling its latest advancements in molecular point-of-care diagnostics at Euromedlab 2023 in Rome. Visitors can experience the product demonstration at Booth No. 44 in Centro Congressi Roma La Nuvola from May 21 to 25. Pluslife's Dock Pro 8, Mini Dock, and test cards for GBS, Strep A, TV, HPV are among the innovations on display.

One of the highlights of the exhibition is the self-developed, patented technology RNase Hybridization Assisted Amplification (RHAM), the latest isothermal amplification method coupled with a robust reporting system powered by Pluslife's patented enzyme evolution platform. Based on RHAM technology, Pluslife tests have an accuracy up to 99%, specificity up to 100%, and sensitivity up to 98%. Performance studies and reports from different laboratories are shared with onsite visitors. The invention of RHAM is the perfect example of Pluslife's commitment to innovation and progress in healthcare technology.

Pluslife Molecular POCT Solution can help medical providers to differentiate medical admissions and offer appropriate care efficiently. With combo tests like HPV 16/18/45, CT/NG/UU, and RSV/Flu A/Flu B, doctors can identify the cause of diseases directly in the office within 35 minutes, without the need to send patient samples to an external laboratory for traditional nucleic acid testing, which can take 24 hours or more. Moreover, results for single-target tests like COVID-19 can be presented in as little as 7 minutes. Because of the fast turnover time of Pluslife Molecular POCT, healthcare organizations are now equipped with a more efficient diagnostic tool that facilitates timely treatment decisions.

Pluslife Mini Dock and Dock Pro 8 analyzers provide a comprehensive test menu, which can be flexibly used in hospitals, clinics, laboratories, and pharmacies. Unlike other test cards, Pluslife test cards can remain stable and effective without refrigeration or temperature controls. The elimination of the cold chain requirement has significant implications for cost reduction.

Pluslife is excited to participate in EuroMedlab with its latest advancements in Molecular Point-of-Care Testing. The upcoming exhibition of Pluslife will be AACC from July 25 to 27 in Anaheim, USA.